Free Trial

Outlook Therapeutics (OTLK) SEC Filings & 10K Form

Outlook Therapeutics logo
$6.27 -0.20 (-3.09%)
(As of 11/12/2024 ET)

Recent Outlook Therapeutics SEC Filings

DateFilerForm TypeView
10/03/2024
8:22 PM
Gangolli Julian S (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
THURMAN RANDY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
HILZINGER KURT J (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Auffarth Gerd (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:30 PM
Haller Julia A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:53 PM
KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:48 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
7:41 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
6:25 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form DEF 14A
05/15/2024
4:19 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
11:15 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
05/01/2024
5:02 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:18 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/17/2024
8:38 PM
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Syntone Ventures LLC (Filed by)
Form SC 13D/A
04/17/2024
7:21 PM
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Syntone Ventures LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
4:21 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
04/15/2024
3:53 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
3:27 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 424B5
04/07/2024
11:15 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
04/02/2024
3:15 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
11:15 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form EFFECT
04/01/2024
3:53 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 424B3
03/29/2024
1:16 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
03/29/2024
9:39 AM
Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:00 PM
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
03/26/2024
3:20 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:11 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/22/2024
4:00 PM
KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:00 PM
Evanson Jeff (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:00 PM
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
TRENARY C RUSSELL III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
4:24 PM
GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Form SC 13D/A
03/20/2024
4:20 PM
GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Ghiath M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:14 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
3:43 PM
Evanson Jeff (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:18 PM
Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
5:59 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form DEF 14A
02/08/2024
6:00 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form ARS
01/24/2024
5:02 AM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

12/22/2023
4:00 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/06/2023
4:00 PM
Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OTLK) was last updated on 11/12/2024 by MarketBeat.com Staff
From Our Partners